USA - engelska - NLM (National Library of Medicine)

eon labs, inc. - cilostazol (unii: n7z035406b) (cilostazol - unii:n7z035406b) - cilostazol 50 mg - cilostazol tablets, usp are indicated for the reduction of symptoms of intermittent claudication, as demonstrated by an increased walking distance. cilostazol is contraindicated in patients with: teratogenic effects pregnancy category c . cilostazol has been shown to be teratogenic in rats at doses that are greater than 5-times the human mrhd on a body surface area basis. there are no adequate and well-controlled studies in pregnant women. in a rat developmental toxicity study, oral administration of 1000 mg cilostazol/kg/day was associated with decreased fetal weights, and increased incidences of cardiovascular, renal, and skeletal anomalies (ventricular septal, aortic arch and subclavian artery abnormalities, renal pelvic dilation, 14th rib, and retarded ossification). at this dose, systemic exposure to unbound cilostazol in nonpregnant rats was about 5 times the exposure in humans given the mrhd. increased incidences of ventricular septal defect and retarded ossification were also noted at 150 mg/kg/day (5

USA - engelska - NLM (National Library of Medicine)

carilion materials management - cilostazol (unii: n7z035406b) (cilostazol - unii:n7z035406b) - cilostazol 100 mg - cilostazol tablets are indicated for the reduction of symptoms of intermittent claudication, as demonstrated by an increased walking distance. cilostazol is contraindicated in patients with: hypersensitivity to cilostazol or any components of cilostazol (e.g., anaphylaxis, angioedema). teratogenic effects: pregnancy category c . cilostazol has been shown to be teratogenic in rats at doses that are greater than 5-times the human mrhd on a body surface area basis. there are no adequate and well-controlled studies in pregnant women. in a rat developmental toxicity study, oral administration of 1000 mg cilostazol/kg/day was associated with decreased fetal weights, and increased incidences of cardiovascular, renal, and skeletal anomalies (ventricular septal, aortic arch and subclavian artery abnormalities, renal pelvic dilation, 14th rib, and retarded ossification). at this dose, systemic exposure to unbound cilostazol in nonpregnant rats was about 5 times the exposure in humans given the mrhd. increased inciden

USA - engelska - NLM (National Library of Medicine)

stat rx usa llc - cilostazol (unii: n7z035406b) (cilostazol - unii:n7z035406b) - cilostazol 100 mg - cilostazol tablets are indicated for the reduction of symptoms of intermittent claudication, as indicated by an increased walking distance. cilostazol and several of its metabolites are inhibitors of phosphodiesterase iii. several drugs with this pharmacologic effect have caused decreased survival compared to placebo in patients with class iii-iv congestive heart failure. cilostazol tablets are contraindicated in patients with congestive heart failure of any severity. cilostazol tablets are contraindicated in patients with haemostatic disorders or active pathologic bleeding, such as bleeding peptic ulcer and intracranial bleeding. cilostazol tablets inhibit platelet aggregation in a reversible manner. cilostazol tablets are contraindicated in patients with known or suspected hypersensitivity to any of its components. pediatric use: the safety and effectiveness of cilostazol in pediatric patients have not been established. geriatric use: of the total number of subjects (n = 2274) in clinical studies of

USA - engelska - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - cilostazol (unii: n7z035406b) (cilostazol - unii:n7z035406b) - cilostazol tablets are indicated for the reduction of symptoms of intermittent claudication, as indicated by an increased walking distance. cilostazol and several of its metabolites are inhibitors of phosphodiesterase iii. several drugs with this pharmacologic effect have caused decreased survival compared to placebo in patients with class iii-iv congestive heart failure. cilostazol is contraindicated in patients with congestive heart failure of any severity. cilostazol tablets are contraindicated in patients with hemostatic disorders or active pathologic bleeding, such as bleeding peptic ulcer and intracranial bleeding. cilostazol inhibits platelet aggregation in a reversible manner. cilostazol tablets are contraindicated in patients with known or suspected hypersensitivity to any of their components.

USA - engelska - NLM (National Library of Medicine)

physicians total care, inc. - cilostazol (unii: n7z035406b) (cilostazol - unii:n7z035406b) - cilostazol 100 mg - cilostazol tablets, usp are indicated for the reduction of symptoms of intermittent claudication, as indicated by an increased walking distance. cilostazol and several of its metabolites are inhibitors of phosphodiesterase iii. several drugs with this pharmacologic effect have caused decreased survival compared to placebo in patients with class iii-iv congestive heart failure. cilostazol tablets, usp are contraindicated in patients with congestive heart failure of any severity. cilostazol tablets, usp are contraindicated in patients with haemostatic disorders or active pathologic bleeding, such as bleeding peptic ulcer and intracranial bleeding. cilostazol tablets, usp inhibit platelet aggregation in a reversible manner. cilostazol tablets, usp are contraindicated in patients with known or suspected hypersensitivity to any of its components.

USA - engelska - NLM (National Library of Medicine)

direct rx - cilostazol (unii: n7z035406b) (cilostazol - unii:n7z035406b) - cilostazol tablets are indicated for the reduction of symptoms of intermittent claudication, as demonstrated by an increased walking distance. cilostazol tablets are contraindicated in patients with: heart failure of any severity: cilostazol and several of its metabolites are inhibitors of phosphodiesterase iii. several drugs with this pharmacologic effect have caused decreased survival compared to placebo in patients with class iii-iv heart failure. hypersensitivity to cilostazol or any components of cilostazol tablets (e.g., anaphylaxis, angioedema) 8.1 pregnancy teratogenic effects pregnancy category c. cilostazol has been shown to be teratogenic in rats at doses that are greater than 5-times the human mrhd on a body surface area basis. there are no adequate and well-controlled studies in pregnant women. in a rat developmental toxicity study, oral administration of 1000 mg cilostazol/kg/day was associated with decreased fetal weights, and increased incidences of cardiovascular, renal, and skeletal ano

USA - engelska - NLM (National Library of Medicine)

a-s medication solutions - cilostazol (unii: n7z035406b) (cilostazol - unii:n7z035406b) - cilostazol tablets are indicated for the reduction of symptoms of intermittent claudication, as demonstrated by an increased walking distance. cilostazol is contraindicated in patients with: hypersensitivity to cilostazol or any components of cilostazol (e.g., anaphylaxis, angioedema). teratogenic effects: pregnancy category c . cilostazol has been shown to be teratogenic in rats at doses that are greater than 5-times the human mrhd on a body surface area basis. there are no adequate and well-controlled studies in pregnant women. in a rat developmental toxicity study, oral administration of 1000 mg cilostazol/kg/day was associated with decreased fetal weights, and increased incidences of cardiovascular, renal, and skeletal anomalies (ventricular septal, aortic arch and subclavian artery abnormalities, renal pelvic dilation, 14th rib, and retarded ossification). at this dose, systemic exposure to unbound cilostazol in nonpregnant rats was about 5 times the exposure in humans given the mrhd. increased inciden

Malta - engelska - Medicines Authority

libytec pharmaceuticals s.a. 44 kifisias avenue, monumenatl plaza-bldg a, 151 25 maroussi, greece - cilostazol - tablet - cilostazol 100 mg - antithrombotic agents

Malta - engelska - Medicines Authority

teva pharma b.v. (utrecht) swensweg 5, 2031 ga haarlem, netherlands - cilostazol - tablet - cilostazol 100 mg - antithrombotic agents

Malta - engelska - Medicines Authority

galenica s.a. 4 Εleftherias str., 14564, kifissia, greece - cilostazol - tablet - cilostazol 100 mg - antithrombotic agents